Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial

被引：0
作者：
Parikh, P. J. [1 ]
Lee, P. [2 ]
Low, D. [3 ]
Kim, J. [1 ]
Mittauer, K. E. [4 ]
Bassetti, M. F. [5 ]
Glide-Hurst, C. [5 ]
Raldow, A. [6 ]
Yang, Y. [6 ]
Portelance, L. [7 ]
Zaki, B. [8 ]
Kim, H. [9 ]
Mancias, J. D. [10 ]
Ng, J. [11 ]
Pfeffer, R. M. [12 ]
Mueller, A. [13 ]
Kelly, P. [14 ]
Boldrini, L. [15 ]
Fuss, M., Jr. [16 ]
Chuong, M. D. [17 ]
机构：
[1] Henry Ford Canc Inst, Dept Radiat Oncol, Detroit, MI USA
[2] City Hope Natl Med Ctr, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA
[4] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA
[5] Univ Wisconsin, Carbone Canc Ctr, Dept Human Oncol, Madison, WI USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA
[7] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA
[8] Dartmouth Hitchcock Med Ctr, Hanover, NH USA
[9] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA
[10] Harvard Med Sch, Dept Radiat Oncol, Dana Farber Canc Inst, Dept Radiat Oncol,Brigham & Womens Hosp, Boston, MA 02115 USA
[11] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA
[12] Assuta Med Ctr, Tel Aviv, Israel
[13] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[14] Orlando Hlth Canc Inst, Dept Radiat Oncol, Orlando, FL USA
[15] Fdn Policlin Univ A Gemelli IRCCS, Dept Radiol Radiat Oncol & Hematol, Rome, Italy
[16] ViewRay Inc, Mountain View, CA USA
[17] Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA 09
引用
收藏
页码：1062 / 1063
页数：2
相关论文
共 50 条
  • [41] A randomized, phase II clinical trial of preoperative stereotactic body radiation therapy versus conventionally fractionated chemoradiation for resectable, borderline-resectable, or locally advanced type a pancreatic adenocarcinoma.
    Hall, William Adrian
    Tsai, Susan
    Banerjee, Anjishnu
    George, Ben
    Ritch, Paul S.
    Thomas, James P.
    Paulson, Eric
    Christians, Kathleen K.
    Clarke, Callisia
    Dua, Kulwinder
    Khan, Abdul H.
    Knechtges, Paul
    Hagen, Catherine E.
    Evans, Douglas B.
    Erickson, Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Preliminary analysis of an ongoing phase II study of MR-guided hypofractionated adaptive radiation with concurrent chemotherapy and consolidation durvalumab for locally-advanced non-small cell lung cancer
    Vlacich, Gregory
    Waqar, Saiama
    Chaudhuri, Aadel
    Robinson, Clifford
    Badiyan, Shahed
    Bergom, Carmen
    Govindan, Ramaswamy
    Morgensztern, Daniel
    Devarakonda, Siddhartha
    Samson, Pamela
    RESPIROLOGY, 2023, 28 : 19 - 19
  • [43] Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial
    Wang, Haohua
    Zhang, Xiang
    Leng, Boyu
    Zhu, Kunli
    Jiang, Shumei
    Feng, Rui
    Dou, Xue
    Shi, Fang
    Xu, Lei
    Yue, Jinbo
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [44] Tislelizumab Plus Zanubrutinib in Patients with Richter Transformation: Primary Endpoint Analysis of the Prospective, Multi-Center, Phase-II RT1 Trial of the German CLL Study Group
    Al-Sawaf, Othman
    Ligtvoet, Rudy
    Robrecht, Sandra
    Stumpf, Janina
    Fink, Anna Maria
    Tausch, Eugen
    Schneider, Christof
    Boettcher, Sebastian
    Mikusko, Martin
    Ritgen, Matthias
    Schetelig, Johannes
    Von Tresckow, Julia
    Vehling-Kaiser, Ursula
    Wendtner, Clemens-Martin
    Fischer, Kirsten
    Kreuzer, Karl Anton
    Stilgenbauer, Stephan
    Staber, Philipp Bernhard
    Niemann, Carsten Utoft
    Hallek, Michael
    Eichhorst, Barbara F.
    BLOOD, 2023, 142
  • [45] Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10
    Chuong, M. D.
    Kirsch, C.
    Herrera, R.
    Rubens, M.
    Gungor, G.
    Schaff, E. M.
    Dolan, J.
    Kim, J.
    Mittauer, K. E.
    Kotecha, R.
    Gutierrez, A.
    Doemer, A. J.
    Ugurluer, G.
    Kwon, D.
    Khan, G.
    Alvarez, D.
    Ucar, A.
    Asbun, H.
    Ozyar, E.
    Parikh, P. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S147 - S148
  • [46] Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)
    Gao, Suizhi
    Zhu, Xiaofei
    Shi, Xiaohan
    Cao, Kai
    Bian, Yun
    Jiang, Hui
    Wang, Kaixuan
    Guo, Shiwei
    Zhang, Huojun
    Jin, Gang
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [47] Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)
    Suizhi Gao
    Xiaofei Zhu
    Xiaohan Shi
    Kai Cao
    Yun Bian
    Hui Jiang
    Kaixuan Wang
    Shiwei Guo
    Huojun Zhang
    Gang Jin
    Radiation Oncology, 14
  • [48] Postoperative Radiotherapy Involving Tumor Bed with or without Elective Nodal Irradiation in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-Center, Prospective Randomized Phase II Trial
    Zeng, Y.
    Cai, X.
    Li, J.
    Ye, J.
    Han, G.
    Luo, W.
    Wu, C.
    Qin, S.
    Gu, W.
    Zhao, S.
    Zhao, Y.
    Xia, B.
    Du, X.
    Liu, Y.
    Fu, X. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S119 - S119
  • [49] Evaluation of low-dose fractionated radiation therapy as a chemopotentiator of gemcitabine in advanced pancreatic cancer: results from an international multi-institutional phase II trial
    Sharma, Navesh K.
    Pandya, Naimish B.
    Wong, Raimond K.
    Herman, Joseph M.
    Hanna, Nader N.
    Laheru, Daniel A.
    Major, Pierre P.
    Alexander, H. Richard
    Kennedy, Nancy L.
    Regine, William F.
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (04) : 401 - 409
  • [50] Prospective Phase II Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed By Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non -Small Cell Lung Cancer (LA NSCLC)
    Heinzerling, J. H., II
    Mileham, K.
    Robinson, M.
    Symanowski, J. T.
    Induru, R.
    Corso, C. D.
    Brouse, G.
    Prabhu, R. S.
    Haggstrom, D.
    Moeller, B. J.
    Bobo, W. E.
    Fasola, C.
    Thakkar, V. V.
    Gregory, J.
    Burri, S. H.
    Simone, C. B., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S27 - S28
12345